These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 33846305)

  • 1. Atlas of breast cancer infiltrated B-lymphocytes revealed by paired single-cell RNA-sequencing and antigen receptor profiling.
    Hu Q; Hong Y; Qi P; Lu G; Mai X; Xu S; He X; Guo Y; Gao L; Jing Z; Wang J; Cai T; Zhang Y
    Nat Commun; 2021 Apr; 12(1):2186. PubMed ID: 33846305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis.
    Savas P; Virassamy B; Ye C; Salim A; Mintoff CP; Caramia F; Salgado R; Byrne DJ; Teo ZL; Dushyanthen S; Byrne A; Wein L; Luen SJ; Poliness C; Nightingale SS; Skandarajah AS; Gyorki DE; Thornton CM; Beavis PA; Fox SB; ; Darcy PK; Speed TP; Mackay LK; Neeson PJ; Loi S
    Nat Med; 2018 Jul; 24(7):986-993. PubMed ID: 29942092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell RNA sequencing of human breast tumour-infiltrating immune cells reveals a γδ T-cell subtype associated with good clinical outcome.
    Boufea K; González-Huici V; Lindberg M; Symeonides S; Oikonomidou O; Batada NN
    Life Sci Alliance; 2021 Jan; 4(1):. PubMed ID: 33268347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment.
    Azizi E; Carr AJ; Plitas G; Cornish AE; Konopacki C; Prabhakaran S; Nainys J; Wu K; Kiseliovas V; Setty M; Choi K; Fromme RM; Dao P; McKenney PT; Wasti RC; Kadaveru K; Mazutis L; Rudensky AY; Pe'er D
    Cell; 2018 Aug; 174(5):1293-1308.e36. PubMed ID: 29961579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer.
    Zhang Y; Li Z; Chen M; Chen H; Zhong Q; Liang L; Li B
    Breast Cancer; 2020 Jul; 27(4):573-585. PubMed ID: 31960363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune gene expression profiling reveals heterogeneity in luminal breast tumors.
    Zhu B; Tse LA; Wang D; Koka H; Zhang T; Abubakar M; Lee P; Wang F; Wu C; Tsang KH; Chan WC; Law SH; Li M; Li W; Wu S; Liu Z; Huang B; Zhang H; Tang E; Kan Z; Lee S; Park YH; Nam SJ; Wang M; Sun X; Jones K; Zhu B; Hutchinson A; Hicks B; Prokunina-Olsson L; Shi J; Garcia-Closas M; Chanock S; Yang XR
    Breast Cancer Res; 2019 Dec; 21(1):147. PubMed ID: 31856876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single-cell and spatially resolved atlas of human breast cancers.
    Wu SZ; Al-Eryani G; Roden DL; Junankar S; Harvey K; Andersson A; Thennavan A; Wang C; Torpy JR; Bartonicek N; Wang T; Larsson L; Kaczorowski D; Weisenfeld NI; Uytingco CR; Chew JG; Bent ZW; Chan CL; Gnanasambandapillai V; Dutertre CA; Gluch L; Hui MN; Beith J; Parker A; Robbins E; Segara D; Cooper C; Mak C; Chan B; Warrier S; Ginhoux F; Millar E; Powell JE; Williams SR; Liu XS; O'Toole S; Lim E; Lundeberg J; Perou CM; Swarbrick A
    Nat Genet; 2021 Sep; 53(9):1334-1347. PubMed ID: 34493872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers.
    Gray MJ; Gong J; Hatch MM; Nguyen V; Hughes CC; Hutchins JT; Freimark BD
    Breast Cancer Res; 2016 May; 18(1):50. PubMed ID: 27169467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonality, Antigen Recognition, and Suppression of CD8
    Hammerl D; Massink MPG; Smid M; van Deurzen CHM; Meijers-Heijboer HEJ; Waisfisz Q; Debets R; Martens JWM
    Clin Cancer Res; 2020 Jan; 26(2):505-517. PubMed ID: 31649042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin repertoire of B lymphocytes infiltrating breast medullary carcinoma.
    Kotlan B; Simsa P; Foldi J; Fridman WH; Glassy M; McKnight M; Teillaud JL
    Hum Antibodies; 2003; 12(4):113-21. PubMed ID: 15156099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive evaluation of methods to assess overall and cell-specific immune infiltrates in breast cancer.
    Nederlof I; De Bortoli D; Bareche Y; Nguyen B; de Maaker M; Hooijer GKJ; Buisseret L; Kok M; Smid M; Van den Eynden GGGM; Brinkman AB; Hudecek J; Koster J; Sotiriou C; Larsimont D; Martens JWM; van de Vijver MJ; Horlings HM; Salgado R; Biganzoli E; Desmedt C
    Breast Cancer Res; 2019 Dec; 21(1):151. PubMed ID: 31878981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell receptor sequencing of early-stage breast cancer tumors identifies altered clonal structure of the T cell repertoire.
    Beausang JF; Wheeler AJ; Chan NH; Hanft VR; Dirbas FM; Jeffrey SS; Quake SR
    Proc Natl Acad Sci U S A; 2017 Nov; 114(48):E10409-E10417. PubMed ID: 29138313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen presentation and interferon signatures in B cells driven by localized ablative cancer immunotherapy correlate with extended survival.
    Liu K; Hoover AR; Krawic JR; DeVette CI; Sun XH; Hildebrand WH; Lang ML; Axtell RC; Chen WR
    Theranostics; 2022; 12(2):639-656. PubMed ID: 34976205
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunoglobulin variable regions usage by B-lymphocytes infiltrating a human breast medullary carcinoma.
    Kotlan B; Gruel N; Zafrani B; Füredi G; Foldi J; Petranyi GG; Fridman WH; Teillaud JL
    Immunol Lett; 1999 Feb; 65(3):143-51. PubMed ID: 10065736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-infiltrating B lymphocytes as an efficient source of highly specific immunoglobulins recognizing tumor cells.
    Pavoni E; Monteriù G; Santapaola D; Petronzelli F; Anastasi AM; Pelliccia A; D'Alessio V; De Santis R; Minenkova O
    BMC Biotechnol; 2007 Oct; 7():70. PubMed ID: 17945015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor mutation burden, immune checkpoint crosstalk and radiosensitivity in single-cell RNA sequencing data of breast cancer.
    Jang BS; Han W; Kim IA
    Radiother Oncol; 2020 Jan; 142():202-209. PubMed ID: 31767471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Molecular Portrait of High-Grade Ductal Carcinoma In Situ.
    Abba MC; Gong T; Lu Y; Lee J; Zhong Y; Lacunza E; Butti M; Takata Y; Gaddis S; Shen J; Estecio MR; Sahin AA; Aldaz CM
    Cancer Res; 2015 Sep; 75(18):3980-90. PubMed ID: 26249178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-155 coordinates the immunological landscape within murine melanoma and correlates with immunity in human cancers.
    Ekiz HA; Huffaker TB; Grossmann AH; Stephens WZ; Williams MA; Round JL; O'Connell RM
    JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30721153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recharacterizing Tumor-Infiltrating Lymphocytes by Single-Cell RNA Sequencing.
    Zhang L; Zhang Z
    Cancer Immunol Res; 2019 Jul; 7(7):1040-1046. PubMed ID: 31262773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer.
    Bense RD; Sotiriou C; Piccart-Gebhart MJ; Haanen JBAG; van Vugt MATM; de Vries EGE; Schröder CP; Fehrmann RSN
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27737921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.